Evidence map›Paper›PMID 21866433›Full record

ReviewEuropean radiology2011

Contrast induced nephropathy: updated ESUR Contrast Media Safety Committee guidelines.

Fulvio Stacul, Aart J van der Molen, Peter Reimer, Judith A W Webb, Henrik S Thomsen, Sameh K Morcos, Torsten Almén, Peter Aspelin, Marie-France Bellin, Olivier Clement and 2 more

Registry-linked trialAbstract readReview
PubMed Publisher
In one paragraph

Review in European radiology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03914950 (Evaluation of the Diagnostic Value of TOF-18F-FDG-PET/CT in Patients With Suspected Pancreatic Cancer), which is not on this map. Cited by 375 papers, 19 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
375citing papers in PubMed, 19 pooled it
29.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03914950 nacompletednot on this mapstarted 2014, after this paper: background citation

Evaluation of the Diagnostic Value of TOF-18F-FDG-PET/CT in Patients With Suspected Pancreatic Cancer

TypeinterventionalSponsorMedical University of GrazRan2014 to 2019Enrolled174ConditionsPancreatic Cancer, Pancreatitis, IPMNArmsPET/CT results with TOF/without TOF
3 · Its place in the literature

Who cites it

375 citing papers in PubMed, 19 syntheses or guidelines pooled it, 873 citations in OpenAlex.

  1. [Hospital diabetes management (Update 2026)].Wiener klinische Wochenschrift · 2026
    Guideline
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. FermentedRenal failure · 2024
    Pooled it
  9. Guideline
  10. Guideline
  11. Pooled it
  12. Pooled it
  13. Pooled it
  14. Pooled it
  15. Pooled it
  16. Pooled it
  17. Pooled it
  18. Guideline
  19. Pooled it
  20. Trial

315 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 10 institutions in 9 countries.

Fulvio StaculS.C. Radiologia Ospedale Maggiore, Piazza Ospitale 1, 34134 Tieste, Italy.
Aart J van der Molen
Peter Reimer
Judith A W Webb
Henrik S Thomsen
Sameh K Morcos
Torsten Almén
Peter Aspelin
Marie-France Bellin
Olivier Clement
Gertraud Heinz-Peer
Contrast Media Safety Committee of European Society of Urogenital Radiology (ESUR)
Copenhagen University Hospital · DKHôpital Broca · FRHôpital Européen · FRKarolinska University Hospital · SELeiden University Medical Center · NLNorthern General Hospital · GBOspedale Maggiore · ITUniversity of Freiburg · DEUniversity of London · GBVienna General Hospital · AT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeThe Contrast Media Safety Committee (CMSC) of the European Society of Urogenital Radiology (ESUR) has updated its 1999 guidelines on contrast medium-induced nephropathy (CIN). AREAS COVERED: Topics reviewed include the definition of CIN, the choice of contrast medium, the prophylactic measures used to reduce the incidence of CIN, and the management of patients receiving metformin. Key Points • Definition, risk factors and prevention of contrast medium induced nephropathy are reviewed. • CIN risk is lower with intravenous than intra-arterial iodinated contrast medium. • eGFR of 45 ml/min/1.73 m (2) is CIN risk threshold for intravenous contrast medium. • Hydration with either saline or sodium bicarbonate reduces CIN incidence. • Patients with eGFR ≥ 60 ml/min/1.73 m (2) receiving contrast medium can continue metformin normally.

Indexed as

Contrast MediaCoronary AngiographyEuropeFemaleFluid TherapyGadoliniumGlomerular Filtration RateHeart FailureHumansInjections, Intra-ArterialInjections, IntravenousIodineMalePractice Guidelines as TopicRenal InsufficiencyRisk FactorsContrast MediaGadoliniumIodineSodium BicarbonateSodium Chloride

Identifiers

PMID21866433
OpenAlexW2061514693

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.